middle.news

ReNerve takes NervAlign into India as quarterly sales hit $584,000

9:18am on Tuesday 17th of November, 2026 AEDT • Medical Devices
Read Story

ReNerve takes NervAlign into India as quarterly sales hit $584,000

9:18am on Tuesday 17th of November, 2026 AEDT
Key Points
  • First commercial NervAlign Nerve Cuff use in India
  • Bangalore procedure performed for an upper-extremity nerve repair
  • September-quarter sales reached a record $584,000
  • NetCentrix Ventures leading local commercialisation and distribution
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Renerve (ASX:RNV)
OPEN ARTICLE